Placental growth factor concentration in maternal circulation decreases after fetal death: lessons from a case series study.

about

Placental growth factor concentration in maternal circulation decreases after fetal death: lessons from a case series study.

Item

http://www.wikidata.org/entity/Q38458497

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Placental growth factor concen ...... sons from a case series study.

@en

type

Item

label

Placental growth factor concen ...... sons from a case series study.

@en

prefLabel

Placental growth factor concen ...... sons from a case series study.

@en

P1476

Placental growth factor concen ...... sons from a case series study.

@en

P2093

Eden Shusterman

http://www.w3.org/2001/XMLSchema#string

Irit Szaingurten-Solodkin

http://www.w3.org/2001/XMLSchema#string

Ofer Beharier

http://www.w3.org/2001/XMLSchema#string

Reli Hershkovitz

http://www.w3.org/2001/XMLSchema#string

Shani S Swissa

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor

Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis

Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies.

The discovery of placenta growth factor and its biological activity.

The vascular endothelial growth factor family in adverse pregnancy outcomes.

Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction.

An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study.

Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model

P2888

s00404-015-3729-7

P304

1027-1032

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00404-015-3729-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

292

http://www.w3.org/2001/XMLSchema#string

P50

Daniel Gitler

Adi Yehuda Weintraub

Eyal Sheiner

P577

2015-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1037525467

http://www.w3.org/2001/XMLSchema#string

P698

25940355

http://www.w3.org/2001/XMLSchema#string

P921

maternal death

stillbirth